Bicycle Therapeutics plc

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Bicycle Therapeutics plc
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Year founded
2017
Jurisdiction of incorporation
United Kingdom
Headquarters city
Cambridge
Headquarters country
United Kingdom
Fiscal year end
December
Ticker symbol
BCYC
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001761612
UK company number
11036004
Wikidata ID
Q104480022

Board of directors

Follow this board

Former directors

Chief executives

Kevin Lee · Chief Executive Officer
Dates unknown

Board connections

7 of this board's directors also sit on 22 other boards. 22 are in the same sector.

Network of Bicycle Therapeutics plc's board connections BeOne Medicines Ltd. BeOne Medicines Ltd. Incyte Corp. Incyte Corp. ACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals... DBV Technologies S.A. DBV Technologies S.A. Denali Therapeutics Inc. Denali Therapeutics In... Immunocore Holdings plc Immunocore Holdings pl... Kiniksa Pharmaceuticals International plc Kiniksa Pharmaceutical... Kodiak Sciences Inc Kodiak Sciences Inc Kymera Therapeutics Inc. Kymera Therapeutics In... Madrigal Pharmaceuticals Inc. Madrigal Pharmaceutica... Neurogene Inc. Neurogene Inc. Prelude Therapeutics Incorporated Prelude Therapeutics I... Replimune Group Inc. Replimune Group Inc. TScan Therapeutics Inc. TScan Therapeutics Inc... vTv Therapeutics Inc. vTv Therapeutics Inc. Century Therapeutics Inc. Century Therapeutics I... Alessandro Riva Alessandro Riva Felix Baker Felix Baker Herve Hoppenot Herve Hoppenot Julian Baker Julian Baker Bicycle Therapeutics plc
Shared director Other board Same sector +6 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$521,394
47 sales by 8 insiders
Date Insider Transaction Shares Price Value
Oct 5, 2026 Skynner Michael Officer (CHIEF SCIENTIFIC OFFICER) Open-market sale −503 $3.57 $1,796
Oct 5, 2026 Kevin Lee Director, Officer (CHIEF EXECUTIVE OFFICER) Open-market sale −1,638 $3.57 $5,848
Oct 5, 2026 Thompson Travis Alvin Officer (Chief Financial Officer) Open-market sale −79 $3.57 $282
Oct 5, 2026 Hannay Michael Charles Ferguson Officer (CHIEF PROD & SUPPLY CHAIN OFF) Open-market sale −242 $3.57 $864
Oct 5, 2026 Perry Jennifer Scott Officer (Chief Operating Officer) Open-market sale −80 $3.56 $285
Oct 5, 2026 Perry Jennifer Scott Officer (Chief Operating Officer) Open-market sale −326 $3.78 $1,232
Oct 2, 2026 Skynner Michael Officer (CHIEF SCIENTIFIC OFFICER) Open-market sale −1,942 $3.47 $6,739
Oct 2, 2026 Kevin Lee Director, Officer (CHIEF EXECUTIVE OFFICER) Open-market sale −6,167 $3.47 $21,399
Oct 2, 2026 Thompson Travis Alvin Officer (Chief Financial Officer) Open-market sale −893 $3.47 $3,099
Oct 2, 2026 Hannay Michael Charles Ferguson Officer (CHIEF PROD & SUPPLY CHAIN OFF) Open-market sale −1,572 $3.47 $5,455
Oct 2, 2026 Robert Charles Swanton Director Open-market sale −3,431 $3.47 $11,906
Oct 2, 2026 Perry Jennifer Scott Officer (Chief Operating Officer) Open-market sale −1,094 $3.47 $3,796
Jul 6, 2026 Skynner Michael Officer (CHIEF SCIENTIFIC OFFICER) Open-market sale −532 $4.31 $2,293
Jul 6, 2026 Kevin Lee Director, Officer (CHIEF EXECUTIVE OFFICER) Open-market sale −1,737 $4.31 $7,486
Jul 6, 2026 Thompson Travis Alvin Officer (Chief Financial Officer) Open-market sale −104 $4.31 $448

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

Akanda Corp. Nasdaq: AKAN · New Romney, United Kingdom Akari Therapeutics plc Nasdaq: AKTX · Tampa, United Kingdom AstraZeneca PLC NYSE: AZN · Cambridge, United Kingdom Autolus Therapeutics plc American Depositary Share Nasdaq: AUTL · London, United Kingdom

Questions about Bicycle Therapeutics plc

Who is the CEO of Bicycle Therapeutics plc?

Kevin Lee is Bicycle Therapeutics plc's Chief Executive Officer.

How many directors are on Bicycle Therapeutics plc's board?

Bicycle Therapeutics plc's board has 21 directors: Alessandro Riva, Alessandro, Riva, Felix Baker, Felix James Baker, Gregory Paul Winter, Herve Hoppenot, Hervé, Hoppenot, Janice Bourque, Jose-Carlos Gutierrez-Ramos, Jose-Carlos Gutierrez-Ramos and 11 others.

Are Bicycle Therapeutics plc insiders buying or selling shares?

Over the last 12 months, Bicycle Therapeutics plc insiders made no open-market purchases and sold $521,394 of shares in 47 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Bicycle Therapeutics plc connected to…? → Spot something wrong? Report a correction
Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here. 

<div data-bod-board="bicycle-therapeutics-plc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.